Hospital Universitario Puerta del Mar -ko ikertzaileekin lankidetzan egindako argitalpenak (196)

2024

  1. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

2023

  1. Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review

    Medicina Clinica, Vol. 161, Núm. 2, pp. 65-77

  2. Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV

    Frontiers in Microbiology, Vol. 14

2022

  1. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response

    World Journal of Hepatology, Vol. 14, Núm. 1, pp. 62-79

  2. Implication of Neutrophils Extracellular Traps in the Pathogenesis of SARS-CoV-2 pneumonia

    Biomedicines, Vol. 10, Núm. 10

  3. ¿Es el momento de incluir a las mujeres transexuales como grupo de riesgo para la vacunación frente al virus del papiloma humano?

    Vacunas

2021

  1. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?

    International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260

  2. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

  3. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1928-1936

  4. Haemophagocytic syndrome and COVID-19

    Clinical Rheumatology, Vol. 40, Núm. 4, pp. 1233-1244

  5. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 9, pp. 1863-1871

  6. Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs

    Scientific Reports, Vol. 11, Núm. 1

  7. Neutrophil Expression of T and B Immunomodulatory Molecules in HIV Infection

    Frontiers in Immunology, Vol. 12

  8. Similarities and differences between hiv and sars-cov-2

    International Journal of Medical Sciences, Vol. 18, Núm. 3, pp. 846-851

2020

  1. HIV antibodies level as a marker of HIV persistence: the role of hepatitis C virus coinfection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 39, Núm. 8, pp. 1503-1512

  2. Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: The NEW_SAFE project

    BMJ Open, Vol. 10, Núm. 7

2019

  1. Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients

    Scientific Reports, Vol. 9, Núm. 1

  2. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy

    Annals of Hematology, Vol. 98, Núm. 8, pp. 1953-1959

  3. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects

    Journal of Neuroimmune Pharmacology, Vol. 14, Núm. 3, pp. 413-422

2018

  1. Acute meningitis

    Medicine (Spain), Vol. 12, Núm. 54, pp. 3198-3209